North Hollywood health care software company ConsejoSano has received an investment from the Bernard J. Tyson Impact Fund.
Biopharma giants Amgen Inc. and Eli Lilly on Thursday announced an antibody manufacturing collaboration for potential COVID-19 treatments.
Amgen Inc. on Tuesday announced its Golden Ticket winners — startup companies BigHat Biosciences and Trilo Therapeutics.
West Hills Hospital will close its obstetrics program effective Nov. 1, the organization announced earlier this month.
Atara Biotherapeutics has received the U.S. Food and Drug Administration’s green light to start clinical trials for its next-generation CAR T therapy.
Amgen Inc. will join the Dow Jones Industrial Index on Aug. 31, according to S&P Dow Jones Indices.
Medical device company Eyenuk Inc. announced U.S. Food and Drug Administration clearance to market its diabetic retinopathy detection software.
Cure Pharmaceutical on Tuesday announced it will acquire privately held Sera Labs in Sherman Oaks for $20 million.
Amgen Inc. beat analyst expectations during the second quarter, despite the effects of the coronavirus on the health care industry.
Arcutis Biotherapeutics on Monday announced the appointment of Dr. Patrick Burnett as its chief medical officer effective Aug. 1.
Thousand Oaks biotech Amgen Inc. on Tuesday announced the renewal of a $3 million grant to Khan Academy.
Medtronic executive Alejandro Galindo will join MannKind Corp. as its chief commercial officer effective Aug. 4.
A Los Angeles skilled nursing home operator will pay $16.7 million to settle allegations with the Department of Justice that it submitted false claims to Medicare for rehabilitation therapy services that were unreasonable or unnecessary.
Amgen on Sunday announced an additional investment of $421 million in Chinese biotech Beigene, adjusting its stock ownership to 20.3 percent.
Medtronic has signed a patent cross-license agreement with San Diego-based Tandem Diabetes Care to avoid potential legal disagreements.